RECOVERY AND TISSUE REPAIR / SIDE BY SIDE
Human Evidence Drops From GHK-Cu to Wolverine
GHK-Cu has small skin tests. The sold fragment borrows claims from a larger protein. Wolverine has no test of the pair.
First check what the researchers actually tested
You can’t give these three names equal weight. Small tests in people covered GHK-Cu skin and hair products. TB-500 claims often come from a larger protein. Wolverine joins two peptides that no study has tested together.
None is approved as a drug used through the whole body. GHK-Cu does have a skin product form. That doesn’t prove a shot is safe. TB-500 and both Wolverine parts have wider gaps. TB-500 lacks its own human trial.
Use the table to check the test, who took part, and the main warning. A mouse result can’t settle your likely outcome. A safety test on another form can’t settle it either. No dose or treatment plan appears here.
Use this table to tie each claim to its test
| What to check | GHK-Cu | TB-500 | Wolverine (BPC-157 + TB-500) |
|---|---|---|---|
| What was measured | Skin cells made collagen and elastin [4][6] | The full thymosin beta-4 protein held actin, which cells use for shape and movement [10][12] | BPC-157 led to new blood vessels in animal and cell work [15]; the full protein behind TB-500 helped cells move; the pair wasn’t tested |
| Main kind of test | Small skin and hair tests in people | Mostly animal injury work; one human safety test used the full protein [11] | Tendon and muscle claims come from separate tests of each part |
| Strength of the work | Small human tests with 13-71 people, plus animal and cell work [1][3][4][5][7] | Most work came before human tests; a 2026 review found little human safety work [8][9] | No test of the pair; two BPC-157 reviews found no sound safety test and no pairing with TB-500 [13][14] |
| Human tests | Small studies on skin or hair [3][4] | One vein test used thymosin beta-4, not the TB-500 piece [11] | None for Wolverine or TB-500; only three small early BPC-157 studies [14] |
| Approval | Copper Tripeptide-1 is an ingredient in skin products; no shot is approved | No approved human use; banned in tested sport | Neither part is approved; both are banned in tested sport |
| Main warning | Use inside the body hasn’t been tested in people | The short piece lacks human safety work [8] | The pair hasn’t been tested, so its safety is unknown [13][14] |
Each peptide was studied for a different repair job
In dishes, GHK-Cu helped skin cells make collagen and elastin [2][4][6]. The paper used a 50%-or-greater rule and left smaller shifts out. That broad result from cells can’t tell you how your skin will change.
TB-500 comes from thymosin beta-4. The full protein grips actin, which helps cells keep shape and move [10][12]. Researchers think the small fragment may still hold actin. Human trials haven’t shown that it does.
Wolverine adds BPC-157 to TB-500. Animal and cell tests tied the added peptide to new blood vessels [15]. Other tests linked the full protein to cell movement. No test watched those two jobs together.
GHK-Cu has human tests; Wolverine has none
GHK-Cu leads this small group in human work. Its tests ranged from 13-71 people [1][3][4][5][7]. They covered skin or hair. They don’t answer questions about deep injuries.
Most TB-500 repair work used rodents. The one human test put thymosin beta-4 into a vein [9][11]. That is the full protein, not TB-500. The small TB-500 piece still lacks a human repair trial. A result for one form can’t prove the other.
No study tested Wolverine as a pair. A 2025 review found 36 BPC-157 studies [13]. Only one involved people. A second review found three small reports in people [14].
Only the GHK-Cu skin ingredient has an allowed use
None of these three is approved as a drug used through the whole body. Copper Tripeptide-1 means GHK-Cu used as a skin product ingredient. For you, that allowed use covers skin care. It doesn’t cover a shot.
TB-500 has no approved medical use. Sports rules ban it. Labs can test for it. Wolverine also contains BPC-157, which sports rules ban.
In 2023, the FDA said pharmacists couldn’t use that substance in specially mixed medicines while it checked safety concerns. The action didn’t settle the safety question. Wolverine still includes the substance under review and adds TB-500. A research label can’t turn a vial into a tested drug. Your doctor can explain what the action means for you.
Each peptide carries a different warning
GHK-Cu has a firm limit around its better work. People in those studies used skin and hair products. Use inside the body is almost untested. A cream result can’t prove that a shot is safe.
TB-500 brings a problem with names. People in the safety test received the full protein. The sold form is one small piece. Check which form a claim asks you to trust.
Wolverine brings an added problem. No controlled study tested both parts together. Researchers haven’t measured its safety. So far, the extra part only adds another unknown.